Preliminary scientific report. Kevin K. Arien, et al. (2021). Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concern.

Neutralization efficacy of antibodies against Omicron variants BA.1 and BA.2 declines quickly. Goethe University Frankfurt. Journal EBioMedicine DOI 10.1016/j.ebiom.2022.104158. Keywords ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing COVID-19 treatment strategies.

The ability of human immunodeficiency virus (HIV-1) to persist and cause AIDS is dependent on its avoidance of antibody-mediated neutralization. The virus elicits abundant, envelope-directed ...

A) The performance of predicting VRC01 neutralization sensitivity on two different sets of viral neutralization data from the CATNAP database. Using only HIV-1 viral envelope amino acid sequence ...

The Biodesix SARS CoV-2 Neutralization Antibody Test has the potential to identify in individuals, the presence (or absence) of this important subset of antibodies that arise after previous ...

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received ...